155 related articles for article (PubMed ID: 12454566)
1. Dosing strategies of clozapine-fluvoxamine cotreatment.
Lu ML; Lane HY; Jann MW; Chang WH
J Clin Psychopharmacol; 2002 Dec; 22(6):626-8. PubMed ID: 12454566
[No Abstract] [Full Text] [Related]
2. Navigating the co-prescription of clozapine and fluvoxamine.
Shymko G; Clark V; Shymko L; Waters F
Schizophr Res; 2018 Dec; 202():391-393. PubMed ID: 30269927
[No Abstract] [Full Text] [Related]
3. Fluvoxamine augmentation in clozapine-resistant schizophrenia: an open pilot study.
Silver H; Kushnir M; Kaplan A
Biol Psychiatry; 1996 Oct; 40(7):671-4. PubMed ID: 8886304
[No Abstract] [Full Text] [Related]
4. Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: drug monitoring and tolerability data from a prospective clinical trial.
Szegedi A; Anghelescu I; Wiesner J; Schlegel S; Weigmann H; Härtter S; Hiemke C; Wetzel H
Pharmacopsychiatry; 1999 Jul; 32(4):148-53. PubMed ID: 10505485
[TBL] [Abstract][Full Text] [Related]
5.
Boyle K; Cornett S; Fijtman A; Hunt-Harrison T
J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):514-515. PubMed ID: 34166111
[No Abstract] [Full Text] [Related]
6. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients.
Lu ML; Lane HY; Chen KP; Jann MW; Su MH; Chang WH
J Clin Psychiatry; 2000 Aug; 61(8):594-9. PubMed ID: 10982203
[TBL] [Abstract][Full Text] [Related]
7. Extrapyramidal symptoms after addition of fluvoxamine to clozapine.
Kuo FJ; Lane HY; Chang WH
J Clin Psychopharmacol; 1998 Dec; 18(6):483-4. PubMed ID: 9864083
[No Abstract] [Full Text] [Related]
8. Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine.
Ozdemir V; Kalow W; Okey AB; Lam MS; Albers LJ; Reist C; Fourie J; Posner P; Collins EJ; Roy R
J Clin Psychopharmacol; 2001 Dec; 21(6):603-7. PubMed ID: 11763009
[TBL] [Abstract][Full Text] [Related]
9. Clozapine-associated development of second-onset obsessive compulsive symptoms in schizophrenia: impact of clozapine serum levels and fluvoxamine add-on.
Gahr M; Rehbaum K; Connemann BJ
Pharmacopsychiatry; 2014 May; 47(3):118-20. PubMed ID: 24846087
[TBL] [Abstract][Full Text] [Related]
10. [Addition of fluvoxamine to clozapine: theory and practice].
Wigard ME; van Gool AR; Schulte PF
Tijdschr Psychiatr; 2013; 55(2):113-21. PubMed ID: 23408363
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical correlates of "high-dose" clozapine therapy for treatment-refractory schizophrenia.
Buckley PF; Friedman L; Krowinski AC; Eaton Y; Tronetti M; Miller DD
Schizophr Res; 2001 Apr; 49(1-2):225-7. PubMed ID: 11428347
[No Abstract] [Full Text] [Related]
12. Adjunctive fluvoxamine with clozapine.
Lu ML; Lane HY
Br J Psychiatry; 2003 Jan; 182():81. PubMed ID: 12509328
[No Abstract] [Full Text] [Related]
13. A Case of Mutism in Noncatatonic Schizophrenia Responding to Small Dose of Fluvoxamine Addition to Clozapine.
Hirakawa H; Terao T; Tanaka T; Sato H; Yoshimura R
J Clin Psychopharmacol; 2016 Oct; 36(5):531-2. PubMed ID: 27508430
[No Abstract] [Full Text] [Related]
14. Increasing the clozapine: norclozapine ratio with co-administration of fluvoxamine to enhance efficacy and minimize side effects of clozapine therapy.
Légaré N; Grégoire CA; De Benedictis L; Dumais A
Med Hypotheses; 2013 Jun; 80(6):689-91. PubMed ID: 23490199
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophan.
Aymard N; Viala A; Baldacci C; Smagghe PO; Vacheron MN; Caroli F
Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):25-41. PubMed ID: 10368854
[TBL] [Abstract][Full Text] [Related]
16. Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients.
Repo-Tiihonen E; Eloranta A; Hallikainen T; Tiihonen J
Neuropsychobiology; 2005; 51(4):173-6. PubMed ID: 15870506
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances.
Lu ML; Lane HY; Lin SK; Chen KP; Chang WH
J Clin Psychiatry; 2004 Jun; 65(6):766-71. PubMed ID: 15291653
[TBL] [Abstract][Full Text] [Related]
18. The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review.
Polcwiartek C; Nielsen J
Psychopharmacology (Berl); 2016 Mar; 233(5):741-50. PubMed ID: 26626327
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of clozapine-fluvoxamine combination.
Peritogiannis V; Tsouli S; Pappas D; Mavreas V
Schizophr Res; 2005 Nov; 79(2-3):345-6. PubMed ID: 16125905
[No Abstract] [Full Text] [Related]
20. Clozapine: more than 900 mg/day may be needed.
Maccall C; Billcliff N; Igbrude W; Natynczuk S; Spencer EP; Flanagan RJ
J Psychopharmacol; 2009 Mar; 23(2):206-10. PubMed ID: 18515467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
